TickerFacts.

Myriad Genetics Inc (MYGN): EPS (Diluted)

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2017-06-30 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

-$3.95
Year ended 2025-12-31
$2.252009-06-30: $0.862010-06-30: $1.542011-06-30: $1.102012-06-30: $1.302013-06-30: $1.772014-06-30: $2.252015-06-30: $1.072016-06-30: $1.602017-06-30: $0.252018-06-30: $1.852019-06-30: $0.062020-12-31: -$2.992021-12-31: -$0.352022-12-31: -$1.392023-12-31: -$3.182024-12-31: -$1.412025-12-31: -$3.95-$3.95
2009-06-30 EPS (Diluted) (USD per share) 2025-12-31
Period endedEPS (Diluted)Change YoYSource filing
2025-12-31-$3.95n/m2026-02-24, From 2025-01-01
2024-12-31-$1.41n/m2026-02-24, From 2024-01-01
2023-12-31-$3.18n/m2026-02-24, From 2023-01-01
2022-12-31-$1.39n/m2025-02-28, From 2022-01-01
2021-12-31-$0.35n/m2024-02-28, From 2021-01-01
2020-12-31-$2.99n/a2022-02-25, From 2020-01-01
No annual figure between 2019-06-30 and 2020-12-31.
2019-06-30$0.06-96.8%2022-02-25, From 2018-07-01
2018-06-30$1.85+640.0%2020-08-13, From 2017-07-01
2017-06-30$0.25n/c2019-08-13, From 2016-07-01
2016-06-30$1.60+49.5%2018-08-24, From 2015-07-01
2015-06-30$1.07-52.4%2018-08-24, From 2014-07-01
2014-06-30$2.25+27.1%2016-08-10, From 2013-07-01
2013-06-30$1.77+36.2%2015-08-12, From 2012-07-01
2012-06-30$1.30+18.2%2014-08-13, From 2011-07-01
2011-06-30$1.10-28.6%2013-08-14, From 2010-07-01
2010-06-30$1.54+79.1%2012-08-15, From 2009-07-01
2009-06-30$0.86n/a2011-08-15, From 2008-07-01

EPS (Diluted) at similar companies

Companies with the same SEC industry code (In Vitro & In Vivo Diagnostic Substances), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedEPS (Diluted)Change YoY
Myriad Genetics Inc (MYGN)2025-12-31-$3.95n/m
Neogen Corp (NEOG)2026-05-31-$0.04n/m
Lantheus Holdings, Inc. (LNTH)2025-12-31$3.41-21.8%
QuidelOrtho Corp (QDEL)2025-12-28-$16.69n/m
Idexx Laboratories Inc (IDXX)2025-12-31$13.08+22.6%
Intellia Therapeutics, Inc. (NTLA)2025-12-31-$3.81n/m
Alpha Teknova, Inc. (TKNO)2025-12-31-$0.32n/m
Immucell Corp (ICCC)2025-12-31-$0.12n/m
Aspira Women's Health Inc. (AWHL)2025-12-31-$0.37n/m

Compare MYGN, NEOG, LNTH, QDEL side by side · Screen every company in In Vitro & In Vivo Diagnostic Substances ↗